Consensus NICE Ltd.

Equities

NICE

IL0002730112

Market Closed - TEL AVIV STOCK EXCHANGE Other stock markets 10:24:51 2024-05-28 am EDT			5-day change	1st Jan Change
70,930 ^ILa	+1.14%		-1.99%	-2.17%

May. 17	NICE's Solid Q1 Overshadowed by Surprise CEO Transition, RBC Says	MT
May. 17	Wedbush Adjusts NICE's PT to $250 From $270, Notes Potential Disruption to Business During CEO Transition; Keeps Outperform Rating	MT

Evolution of the average Target Price on NICE Ltd.

Price target over the last 5 years

History of analyst recommendation changes

972f787845a2991b348c2b803ad1798e.34Ek8qu9fxuNUQKyAVg5L5hNTWDL0akDdg3OFzuSKBg.nNAQlf3cDmrjNVTjexRefKx_BzCxg-UxNV2ZX2vQb12s2G3An4opWrwbbQ~4516c127d72cf06df8f2779df2322665

Analyst Recommendations on NICE Ltd.

Wedbush Adjusts NICE's PT to $250 From $270, Notes Potential Disruption to Business During CEO Transition; Keeps Outperform Rating	May. 17	MT
JMP Securities Cuts Price Target on NICE to $300 From $343, Maintains Market Outperform Rating	May. 17	MT
Mizuho Cuts Price Target on NICE to $280 From $300, Maintains Buy Rating	May. 17	MT
RBC Cuts Price Target on NICE to $265 From $285, Says 'CEO Transition Represents Meaningful Risk,' Keeps Outperform Rating	May. 17	MT
DA Davidson Upgrades NICE to Buy From Neutral, Adjusts Price Target to $300 From $250	Mar. 13	MT
Mizuho Ups Price Target on NICE to $300 From $244, Keeps Buy Rating	Feb. 23	MT
Barclays Raises NICE's Price Target to $320 From $283, Keeps Overweight Rating	Feb. 23	MT
Oppenheimer Raises NICE Price Target to $300 From $225, Maintains Outperform Rating	Feb. 23	MT
RBC Raises Price Target on NICE to $285 From $238, Keeps Outperform Rating	Feb. 23	MT
Wedbush Raises NICE's PT to $270 From $230 After 'Strong' Q4 2023 Results, Keeps Outperform Rating	Feb. 23	MT
Citigroup Adjusts NICE's Price Target to $334 From $283, Keeps Buy Rating	Feb. 21	MT
Morgan Stanley Raises Price Target on NICE to $260 From $220, Keeps Overweight Rating	Dec. 14	MT
Morgan Stanley Upgrades NICE to Overweight From Equalweight, Cuts Price Target to $220 From $225	23-10-16	MT
Oppenheimer Adjusts NICE Price Target to $225 From $250, Maintains Outperform Rating	23-10-05	MT
Citigroup Adjusts NICE Price Target to $338 From $278, Maintains Buy Rating	23-08-15	MT
William Blair Starts NICE at Outperform	23-07-26	MT
Mizuho Initiates NICE at Buy With $244 Price Target	23-05-31	MT
Jefferies Adjusts Price Target on NICE to $235 From $260, Keeps Buy Rating	23-05-12	MT
Wedbush Cuts NICE's Price Target to $230 From $250 Reflecting Lower Multiple, Keeps Outperform Rating	23-05-12	MT
Citigroup Adjusts Price Target on NICE to $278 From $277, Keeps Buy Rating	23-05-10	MT
Piper Sandler Upgrades NICE to Overweight From Neutral, Adjusts Price Target to $227 From $222	23-01-17	MT
RBC Capital Adjusts Price Target on NICE to $238 From $265, Maintains Outperform Rating	23-01-10	MT
Citigroup Adjusts Price Target on NICE to $260 From $254, Maintains Buy Rating	22-11-11	MT
Morgan Stanley Adjusts NICE's Price Target to $215 from $235, Retains Equalweight Rating	22-10-11	MT
Piper Sandler Starts NICE at Neutral With $236 Price Target	22-08-25	MT